Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK

SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK - an International, Observational Registry

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients with cardiogenic shock treated at a tertiary care hospital. Who Should NOT Join This Trial: - Age ≤17 years. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients with cardiogenic shock treated at a tertiary care hospital. Exclusion Criteria: * Age ≤17 years.

Locations (1)

University Heart Center
Hamburg, Germany